Rheinmetall's €80bn Order Book Faces Its Sternest Test Yet
Published on 08/24/2026 at 06:02 | Redaktion boerse-global.de
The arithmetic at Rheinmetall is becoming increasingly difficult to square. On one side sits an order backlog north of €80bn, a figure that would make most industrial companies the envy of their sector. On the other sits a share price still nursing a 26 percent loss since the start of January, with the gap to its 52-week high of €2,007 now stretching to 42 percent. The disconnect between the Düsseldorf group's commercial momentum and its market valuation has rarely been wider.
A Forecast Cut That Cuts Deeper Than It Looks
The immediate source of investor unease is well documented. Rheinmetall has trimmed its 2026 revenue guidance to a range of €13.7bn to €14.2bn, down from the previous €14.0bn to €14.5bn. The trigger was the German defence ministry's decision on 24 June to halt the F126 frigate programme — a blow that lands squarely on the group's naval systems division.
The adjustment appears modest on paper, yet it has landed with disproportionate weight. That is partly because Rheinmetall had grown accustomed to the Bundeswehr as a dependable anchor client, and partly because the cut arrived just as the group was touting record profitability. First-half revenues of €5.2bn represented a 39 percent year-on-year jump, with operating profit of €786m and second-quarter sales of €3.289bn contributing an operating result of €562m. The market's response to those numbers has been conspicuously muted — the shares have managed only a 0.6 percent gain since publication.
The Order Taps Keep Flowing
What makes the current picture so layered is that the flow of new business shows no sign of abating. Just over a week ago, the Bundeswehr expanded an existing contract for mobile field hospitals and medical stations by more than €500m, with 149 additional systems scheduled for delivery from the first quarter of 2027. Rheinmetall describes it as the largest order ever received by its Project Solutions division.
The same week brought a Danish order for the MASS multi-munition soft-kill system, a naval self-protection suite, with deliveries pencilled in from the fourth quarter of 2027. That followed a demonstration on Wednesday, conducted jointly with sensor specialist Hensoldt, of passive sensor technology integrated into a modern air defence system — a partnership that underscores both companies' ambitions in European defence electronics.
Should investors sell immediately? Or is it worth buying Rheinmetall?
The pattern is clear: the F126 setback is concentrated in one business unit, while land systems, medical logistics and munitions continue to expand. Rheinmetall has also been busy on the partnership front throughout August, with the Bundeswehr hospital order and the Danish MASS contract forming part of a steady cadence of announcements.
Analysts Split on the Path Ahead
The sell-side response to this mixed picture has been characteristically divergent. RBC initiated coverage on 11 August with an "Outperform" rating and a price target of €1,600 — the most bullish call currently on the street. Jefferies followed three days later, lifting its target from €1,300 to €1,350 while maintaining a "Buy" stance. JPMorgan has struck a more cautious tone, reiterating a "Neutral" rating on 17 August with a target of €1,350.
That clustering of targets between €1,350 and €1,600 sits comfortably above Friday's closing price of €1,156.40, suggesting analysts see meaningful upside even after the forecast reduction. The dispersion of views, however, reflects genuine uncertainty about how quickly the group can replace the F126 revenue stream and whether the broader growth trajectory can be sustained.
A Technical Picture in Two Halves
The share price itself tells a story of violent swings. Friday's close represented a 0.3 percent daily decline and a 4.9 percent weekly drop, yet the monthly picture shows a 12 percent gain — a volatility profile that has become characteristic of the stock. The technical indicators are similarly conflicted: the RSI sits at 52.9, squarely in neutral territory, while the price trades roughly 5.6 percent above its 50-day moving average but remains 19 percent below the 200-day line.
That gap between short-term recovery and long-term damage neatly captures the dilemma facing investors. The recent bounce has clawed back only a fraction of this year's losses, and the market's tepid reaction to a steady drumbeat of positive news suggests a degree of scepticism that will not be easily dispelled.
Two upcoming events may provide further clarity. The DZ Bank Expert Day on 27 August and the Berenberg Stockholm Seminar on 1 September both offer platforms for management to address the growth outlook head-on. With the order book providing ample ammunition and the forecast cut now fully absorbed, the onus is on Rheinmetall to demonstrate that the F126 gap is an anomaly rather than the beginning of a trend.
Ad
Rheinmetall Stock: New Analysis - 24 August
Fresh Rheinmetall information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
